Tag: Boehringer
US-Krankenversicherung senkt Pharmapreise um 50 Prozent – Boehringer klagt
Frankfurt Pläne zu drastischen Preissenkungen bei Medikamenten in den USA rütteln die Pharmabranche auf. Die US-Regierung will hohe Rabatte auf häufig verschriebene Produkte bei der staatlichen Krankenversicherung Medicare durchsetzen und…
Boehringer Ingelheim auf dem Weg zum Mega-Blockbuster
Forschung bei Boehringer Ingelheim In den nächsten fünf Jahren will das Unternehmen 25 Milliarden Euro in Forschung und Entwicklung investieren. (Foto: Boehringer Ingelheim) Frankfurt Dank großer Nachfrage nach dem Diabetesmittel Jardiance…
Pharmaceutical industry complains about Germany as a location
Dusseldorf Germany was once the pharmacy of the world. Today pharmaceutical managers are warning that the country is falling behind. “International location competition is tough. We see increasingly attractive conditions…
With German research to number two in the pharmaceutical industry
Frankfurt The German pharmaceutical industry has a long tradition in immunology – and is still very efficient when it comes to researching new medicines. Commercially, two US companies are currently…
Bayer, Boehringer & Merck are fighting for the position
Frankfurt With the huge success in the development of the Covid vaccine, the Mainz-based biotech company Biontech has suddenly risen to become one of the largest German pharmaceutical manufacturers. From…
Bayer, Boehringer & Merck are fighting for the position
Frankfurt With the huge success in the development of the Covid vaccine, the Mainz-based biotech company Biontech has suddenly risen to become one of the largest German pharmaceutical manufacturers. From…
Sanofi, GSK, Boehringer Ingelheim: Investors fear wave of lawsuits
Stomach medication Zantac Several pharmaceutical companies are threatened with lawsuits in the USA because of possible carcinogenic ingredients. (Photo: Reuters) Frankfurt A stomach medicine that has been banned from the…
New remedies for heart failure, cancer, schizophrenia
Frankfurt After several important advances in product development, the pharmaceutical group Boehringer Ingelheim sees itself at the beginning of a new investment offensive in the area of product development and…